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INTRODUCTION 
Rabies has been ecognized from very ancient times as a disease 
transmitted to humans and animals by the bite of “mad dogs”. The term 
rabies comes from the Latin word rabidus, meaning mad, derived from 
the Sanskrit root rabhas, for frevazy.  
Rabies also known as hydrophobiais an acute, highly fatal viral 
diseases of the central nervous system caused by Rhabdoverue.  It is 
primarily a zoonetri disease of warm blooded animals, particularly 
caruivorous such as dogs, cats, jackals and wolves. The view is usually 
animal. Although the number of human cases is small, rabies is a major 
public health problem because it is widespread among animal reservoirs. 
Rabies is practically a 100% fatal diseases. Thee are only 3 
recorded survivors till date who recovered full intensive life support and 
excellent nursing care.  However, rabies is preventable with wound care, 
modern vaccines and sera (Immunoglobulins). 
 
AIM OF THE STUDY 
 
 
 To study the epidemiology of dog bitten children 
 To study the knowledge, attitude, practice regarding rabies and 
first aid to dog bite. 
 To study the knowledge, attitude and practice regarding rabies 
vaccination. 
 To study the side effects of rabies vaccination. 
LITERATURE REVIEW 
In the study conducted in IDH Research Centre, Kasali between 
1986 to 1989. Adult male (55%), boys (37.5%), Adult Female (5%), 
Girls (2.5%) are affected with rabies infectious diseases. 
In a study conducted in Hospital in Delhi in 1988, Significantly 
higher number of children are affected, more males affected than 
females.   
In the same study 44.7% are bitten in lower limbs, 37.4% are 
bitten in upper limb, 9.7% bitten head and neck. 
Only 20 of the 206 cases received correct wound care.  3 of the 
206 cases applied oil or red chilly. 
In a study conducted in infectious diseases, Delhi in 1999, 36.7% 
dogbite victims are 5-14 year old.  Male : Female Ratio 4:1  93.4% 
didn’t Receive any local wound care.  
(Indian Journal of Paediatrics 2004, Sep. 15; 71; 217-220. 
55.2%, 30.7%, 2.1% and 12% persons had bites on lower limb, 
upper limb, chest and back and head & neck respectively. 
In a study conducted in S.E. Asian countries.  Dog bite 
prevalence is 200-800 / 1,000,000. 
80% of dog bite victims have bite site pains and parasthesia  50% 
of dog bige victims have paraesthesia / pain at the bite site and it is a 
specific sign of rabies. 
Only 3 cases are long time survivors of rabies.  
18% of FRE roaming healthy dogs have antirabies antibody. 
Only one case of person to person contact of rabies affected baby 
bitten the parent and she developed rabies reported in British Medical 
Journal. 
In the study conducted in S.N. Hospital, Agra from 15.12.1970 to 
15.5.1971 Class II bite is 82.2%, Class III (12.9%). 
Local wound treatment reduce rabies by 80%. 
Dog bite 2nd most common cause of emergency room injuries. 
In the study  conducted in VSG Hospital, Ahamedabad, 1978 – 
1979 publisehd in Journal of Indian Medical Association, April 1981, 
Vol.76, NO.748, 134-136, 38.1% are in age group 5-15 male to female 
ratio 3.3:1, bite in lower limb is 72.3%, upper limb 23%, 2.3% get rabies 
per 1000. Maximum dog bite in November – January. 
In one study in I.D.H., Delhi in 1999, 78% of the victims didn’t 
know about the rate of the Dog 9% Dog killed, 7% Dog died. 
REGIONAL DISTRIBUTION  
23.8% fromurban, 76.2% from Rural population are affected. 
SEVERITY OF EXPOSURE  
72.5% Class II, 27.5% Class II. 
Journal of Indian Medical Association, Sep. 1983; 81; 69-74.  In 
this study conducted in IDH Calcutta from 1979-1980. 35.4$ are in 1-10 
years.  71.7/ male and 22.3% female affected. 5.5% are due to pet dogs 
and 94.5% due to stray dogs.  Culcutta in 1977 had 1.42 lac stray dog. 
In the study conducted from January 1982 – June 1983 in 
Institute of Child Health, on 758 children. Male female Ratio is 2:1, 
55% in 7-10 28%  4-6, 26% 1-3, 9% 10-12 2% < 1 yr. 78%  by pet dog, 
22% by street dogs bite inlower limb is 51% upper limb 31%, face 14% 
.  95% dog alive, 5% untraceable, 4% killed. 
 
HISTORICAL REVIEW 
References to rabies occurs in the Mesopotamian laws of 
Esthunna (Circa 2200 BC). The causative agent of rabies had for 
centuries been associated with the saliva of rabid dogs but it was only is 
1804 that Zinke adduted proof by transmitting the disease be normal 
dogs by the inoculation of saliva from rabid dogs.  
In 1821, Megendie and Breschet infected dogs with saliva from a 
human patient.  Providng the identity of the agen causing the human and 
animal rabies. In a series of study dating from 1881, Pasteur established 
that the rabies varies was present in the brain of infected animals.  By 
serial intracerebral passage in rabbits, he obtained the fixed virus and 
demonstrated that dogs can be rendered mimic by a series of injection of 
fixed virus of graded infectivity.  This vaccine was prepared by drying 
for various periods, pieces of spinal cord from rabbits infected with the 
fixed view. In July 1885, Joseph Meister, a 9 year old boy bitten by a 
rabid dog was given a course of B innoculatasis of the infected cord 
vaccine by Pasteur. The boy survived. This dramatic went was a 
milestone in the development of medicine. 
Other historical key events that contributed to the control of 
human rabies. 
¾ Dev. Of human rabies vaccine – 1885 
¾ Discovery of negribody – 1903 
¾ Use of rabies vaccine for dogs – 1940 
¾ The addition of rabies immuno globilins  to human post exposure 
vaccinatin Rx – 1954 
¾ Growth of rabies virus in cultured cells – 1958. 
¾ Development of diagnostic fluorescent antibody test – 1959. 
 
 
CHAPTER II 
EPIDEMIOLOGY 
Rabies is a viral zoonosis and carnivores such as foxes and 
raccoons, as well as many bat species, are wildlife hosts of the rabies 
virus in nature. Globally, in terms of human disease dogs represent the 
most important reservoir. Infection of humans usually follows bites by 
rabid animals and is almost invariably fatal once signs of disease occur. 
More than 2.5 thousand million people live in regions where rabies is 
endemic. It is estimated that each year at least 50 000 people die from 
rabies, and more than 10 million receive post-exposure vaccination 
against this disease. Children aged 5–15 years are at particular risk. 
More than 99% of all human deaths from rabies occur in Africa, Asia 
and South America; India alone reports 30 000 deaths annually.  
In about 100 countries, rabies is enzootic in both wild and 
domestic animals and poses a potential threat to a considerable 
proportion of the more-than 2.5 thousand million people living in these 
areas. Some island states such as Iceland, Japan and the United 
Kingdom, and European states such as Belgium, Finland, France, 
Greece, Norway, Portugal, Spain, Sweden and Switzerland, are now 
considered free of rabies. 
Among human infections, rabies is believed to be the tenth most 
common cause of death. Once clinical symptoms have occurred, the 
disease is almost invariably fatal. However, reporting is often 
incomplete and the estimated 50 000 deaths per year may be an 
underestimate. Asia accounts for more than 90% of all rabies fatalities. 
India alone reports 30 000 deaths per year, i.e. an annual incidence of 
approximately 3 deaths per 100 000 population. Annual incidences of 
0.01–0.2 deaths per 100 000 are reported from Latin America. In Africa, 
0.001–13 deaths per 100 000 are reported, but rabies is grossly 
underreported in many countries. 
Although all age groups are susceptible, rabies is most common 
in people aged under 15 years, with 30%–50% of post-exposure 
treatments given to children aged 5–14 years, the majority being male. 
The most severe injuries such as multiple head and/or neck bites have 
the shortest incubation period and tend to occur in the youngest children. 
Since many of these exposures are never reported, it is likely that there 
is a high proportion of young children dying from undiagnosed rabies. 
MICROBIOLOGY OF RABIES 
Rabies virus belongs to the genus Lyssavirus within the family 
Rhabdoviridae. The genus Lyssavirus includes seven types, of which 
type 1 represents the classic rabies virus.  
The rabies virus is bullet-shaped and measures approximately 
180 x 75 nm. The RNA genome encodes five proteins: the glycoprotein 
(G) is the primary structural component of the surface spikes embedded 
in the viral envelope and is associated with the smaller M protein. 
Enclosed by the host-cell derived envelope is an infectious viral core of 
nucleocapsid (N) proteins, thus encapsidating the viral genome and the 
RNA polymerase. The NS protein is associated with the nucleocapsid.  
Rabies virus is stable between pH 3 and pH 11 and may survive 
for many years at –70 °C or when freeze-dried and kept at 0 – 4°C. It is 
rapidly inactivated by desiccation, UV and X-ray exposure, sunlight, 
trypsin, b-propiolactone, ether and detergents. 
Protective immune response  
In natural infection, rabies virus is largely unavailable to the 
immune system and the immune response is usually slow. Thus, there is 
a delayed antibody response to both the G and N protein and the number 
of natural killer cells are in general reduced, implying deficits of 
immune recognition or activation. Furthermore, in patients with 
paralytic rabies, lymphocyte proliferation seems to be impaired. 
Following vaccination with modern cell-derived rabies vaccines, 
a prompt and highly protective antibody response is elicited. Immunity 
is believed to depend mainly upon the CD4+ T-cell dependent 
neutralizing antibody response to the G protein. Also, cell-mediated 
immunity has long been recognized as an important part of the defence 
against rabies. Cells presenting fragments of the G protein are the targets 
of cytotoxic T-cells and the N protein induces T-helper cells. 
PATHOLOGY  AND PATHOPHYSIOLOGY 
Rabies is an infection initially of wild and then domestic animals, 
which is spread to humans by bites, contact with mucosal membranes, 
and (to a much lesser extent) aerosol inhalation in bat caves. Most 
infections (90%) are transmitted via domestic animals (cats and dogs), 
mainly due to their closer association with humans. 
Almost all transmissions are via bites. As the virus is excreted in 
saliva, infection can occasionally occur via scratches infected with 
saliva, though the infection rate is 50 times lower.10 Human to human 
transmission has not been recorded, with the exception of six iatrogenic 
cases resulting from corneal graft implants 
Airborne transmission is thought to have occurred in two men 
who inhaled virus aerosols generated in caves inhabited by rabid bats, 
and in a laboratory worker who became infected while rabid sheep 
brains were being ground for vaccine production 
The virus may be shed in breast milk, and there has been at least 
one suspected case of transmission from a mother to a breastfed infant.13 
Transplacental infection occurs in animals but has not been reported in 
humans. A number of women with rabies encephalitis are known to have 
delivered healthy babies.  
The virus may be shed in breast milk, and there has been at least 
one suspected case of transmission from a mother to a breastfed infant.13 
Transplacental infection occurs in animals but has not been reported in 
humans. A number of women with rabies encephalitis are known to have 
delivered healthy babies.  
Pathophysiology 
After a bite, the virus replicates in muscle cells close to the site of 
the bite and then ascends to the central nervous system via the peripheral 
nerves. On reaching the central nervous system, there is massive viral 
replication on membranes within neurones. It is then transmitted directly 
across synapses into efferent nerves, and is deposited in almost every 
body tissue, including the autonomic nervous system via neural 
networks. It is at this stage that productive viral replication occurs with 
budding, particularly in the salivary glands, in preparation for the 
infection of other mammals.  
The incubation period from bite to disease varies widely, but is 
usually between 30 and 90 days. Antigenic analysis has confirmed 
incubation periods of up to 7 years,14 although this is exceptional. Bites 
on the head and neck have a shorter incubation period (sometimes even 
as short as 15 days) compared with those on the trunk and lower 
extremities, due to the decreased length and greater number of neurones.  
RABIES VACCINES  
More than 100 years ago, Louis Pasteur and his colleagues 
developed the first crude rabies vaccine based on attenuated virus from 
desiccated nerve tissue. Unfortunately, the majority of post-exposure 
immunizations against rabies are still performed with vaccines of crude 
nerve tissue origin. Although continuously improved over the years, 
inactivated vaccines produced in sheep or goat brains (Semple) or 
suckling mouse brain (Fuenzalida) may be associated with serious 
adverse events. Possible post-vaccinal neurological reactions may 
include meningoencephalitis, meningoencephalomyelitis, mononeuritis 
multiplex, dorsolumbar transverse myelitis and ascending paralysis of 
the Landry type, usually occurring between one and two weeks after the 
first injection. With the Semple-type vaccines, the incidence of 
neurological reactions varies between 1 in 200 and 1 in 1600 recipients, 
with a lethality of up to 14%. Vaccines of the Fuenzalida type are 
associated with neurological complications in about 1 in 8000 to 1 in 
27 000 courses. Furthermore, in terms of protective potency these 
vaccines are inferior to modern cell-derived vaccines. A complete post-
exposure treatment using nerve tissue vaccines involves a prolonged and 
painful immunization course of up to 23 injections. Obviously, these 
vaccines are not recommended for pre-exposure immunization. 
The human diploid cell rabies vaccine was introduced in 1967 
and is regarded as the gold standard for rabies vaccines. However, the 
more recently developed and less expensive purified chick embryo cell 
vaccine and purified Vero cell rabies vaccine have comparable 
characteristics. They are all lyophilized and must be reconstituted. The 
potency of all cell-derived vaccines is assessed using a National 
Institutes of Health test and the WHO requirement is a potency of at 
least 2.5 IU per intramuscular dose.  
Human diploid cell rabies vaccines are based on the Pitman-
Moore L503 strain or, in one case, the Flury strain of rabies virus. 
Human diploid cell rabies vaccines have been given to more than 1.5 
million people worldwide. Its protective efficacy in situations of heavy 
exposure has been shown in the Islamic Republic of Iran where none of 
45 persons who received post-exposure treatment with this vaccine 
developed rabies following severe bites by rabid dogs or wolves.  
The purified Vero cell rabies vaccine contains the Wistar strain of 
the virus, but with the Vero cell line as substrate. Clinical studies with 
the purified Vero cell vaccine show neutralizing antibody responses 
both after primary and secondary immunizations that are fully 
comparable to those seen after vaccination with the human diploid cell 
vaccines. In Thailand, post-exposure treatment using purified Vero cell 
vaccine and rabies immune globulin has been shown to be protective.  
Purified chick embryo cell rabies vaccine is prepared from 
inactivated rabies virus of the Flury LEP-25 strain. No clinically 
important differences were observed when this vaccine was evaluated 
together with human diploid cell vaccines in studies on post-exposure 
protection of animals and humans and in pre-exposure immunogenicity 
studies. More than 30 million doses of the purified chick embryo cell 
vaccine have been administered worldwide. 
Purified duck embryo rabies vaccine showed similar qualities to 
the other cell-derived rabies vaccines, but is no longer manufactured.  
Despite applying potent, modern, cell-derived vaccines, about 
one "failure" in 1 million post-exposure treatments does occur. Careful 
analyses show that such failures are almost always associated with 
severe lesions on or near the head and/or inappropriate administration of 
the treatment. 
There are no contraindications to any of these vaccines being 
used for post-exposure treatment. Should an allergic reaction occur, the 
modern vaccines of different cell substrate origin may replace each 
other. Pregnancy is not a contraindication to post-exposure treatment. 
Although associated with mild and transient reactions, all the 
cell-derived rabies vaccines are considered safe. With human diploid 
cell vaccines, which are most thoroughly investigated, pain, erythema 
and swelling or itching at the injection site occur among 30%–74% of 
the recipients. Systemic reactions involving headache, nausea, 
abdominal pain, muscle aches or dizziness are reported among 5%–40% 
of vaccinees, and allergic oedema in 0.1%. One study reports fever 
among 3.6% of recipients of the human diploid cell vaccine. Systemic 
allergic reactions characterized by generalized urticaria accompanied in 
some cases by arthralgia, angiooedema, fever, nausea and vomiting have 
been reported. They are uncommon in persons receiving primary 
vaccination, but have occurred in up to 6% of persons receiving a 
booster dose, with onset after 2–21 days. These reactions have been 
shown to follow the development of IgE antibodies to b-propiolactone 
altered human serum albumin in the vaccine (b-propiolactone is used as 
an inactivating agent). According to the manufacturers of purified Vero 
cell rabies vaccine and purified chick embryo cell vaccine, allergic 
reactions are very rare after both primary and booster doses with these 
vaccines. Studies on the purified Vero cell rabies vaccine report local 
and general reactions in 10.6% of post-exposure treatment patients and 
complaints of mild to moderate reactions in 7%. Also, among 
intradermal or intramuscular recipients of this vaccine, low-grade fever 
was the only significant systemic event, occurring in 8% of all subjects 
and most frequently following intramuscular vaccination. In the same 
study, pruritus at the injection site was the only significant local 
reaction. Among 88 healthy adults receiving a total of 292 doses of 
purified chick embryo cell vaccine, 16.4% reported local side-effects, 
whereas 15.1% reported general symptoms.  
Other cell-derived vaccines are available on a national scale only. 
For example, in the United States the Kissling rabies strain has been 
adapted to replication in lung fibroblasts of fetal rhesus monkeys. The 
resulting vaccine, which is given according to the same pre- and post-
exposure schedules as the human diploid cell vaccine, is considered 
equally effective and may less often cause allergic reactions. In Japan, a 
vaccine type similar to the purified chick embryo cell vaccine, but based 
on the Flury HEP strain, has reached limited distribution. A primary 
hamster kidney-cell rabies vaccine is mainly used in China where it was 
licensed in 1989. Each year more than 5 million doses of this vaccine 
are administered in China, where it has now completely replaced the 
Semple-type rabies vaccine.  
PRE EXPOSURE PROPHYLAXIS 
Pre-exposure vaccination may be performed with any of the 
modern cell-derived vaccines and is recommended for anyone at 
increased risk of exposure to rabies virus. Traditionally, this 
recommendation includes laboratory staff, veterinarians, animal 
handlers, wildlife officers with frequent exposure to potentially infected 
animals as well as visitors to highly rabies-enzootic areas who may be 
exposed to rabies hosts. However, according to age-stratified studies of 
incidence, those at greatest risk are probably children living in rabies-
enzootic regions of the developing world. 
The pre-exposure schedule requires intramuscular doses of 1 ml 
or 0.5 ml, depending on the vaccine type, given on days 0, 7 and 28. 
Major vaccine manufacturers recommend one booster dose after one 
year, and to ensure protection in persons at continued risk, booster 
vaccinations every five years, or ideally, at intervals dictated by regular 
testing for antirabies antibodies (titres >0.5 IU/ml required for 
protection). On the other hand, studies with the human diploid cell 
vaccine and the purified Vero cell rabies vaccine have shown that 10 
years after a pre-exposure series followed by a single booster dose after 
one year, more than 96% of the vaccinees still have neutralizing 
antibodies against rabies virus. 
CLINICAL FEATURES OF RABIES 
SYMPTOMS AND SIGNS 
The viral prodrome is non-specific and, particularly in areas 
where the virus is rare, the diagnosis is often made late. In many 
patients, the first symptom is itching, pain, or paraesthesia at the site of a 
healed bite wound. Prodromal symptoms then develop, including fevers, 
myalgia, headache, irritability, depression, and upper airway or 
gastrointestinal symptoms 
PRODROMAL SYMPTOMS OF RABIES  
• Itching, pain, or parasthesia at site of bite wound 
• Fevers 
• Myalgia 
• Headache 
• Irritability or depression 
• Gastrointestinal upset 
• Radiculopathy in bitten limb 
• Proceeding to encephalopathy 
Furious rabies 
This is the more common presentation. It manifests as irritability, 
agitation, and hyperaesthesia. Reported abnormalities include cranial 
nerve lesions, upper motor neurone lesions, and autonomic disturbances 
(disorders of blood pressure, hypersalivation, and sweating). The 
pathognomonic symptom of hydrophobia is a triad of inspiratory muscle 
spasm, painful laryngospasm, and terror (fear of swallowing). It initially 
occurs when trying to drink water but eventually can occur with the 
slightest stimulus or even at the mention of water. In its most severe 
form, the reflex can be provoked simply by drafts, at which point it is 
known as aerophobia. This reflex is combined with extension of the 
back and arms and may even end in a generalised convulsion, or 
cardiorespiratory arrest. Without supportive treatment, approximately 
one third of patients will die within the first few days of a hydrophobic 
spasm. The rest will proceed to a generalised flaccid paralysis and rarely 
survive more than a week without intensive care support. Even with 
such support, the disease is fatal within months, with very few reported 
cases of survival. In one report, all survivors had been given pre-
exposure vaccination and post-exposure prophylaxis.15 Limited recovery 
is often a more appropriate term than survival, as survivors will have 
long term neurological deficits.  
DIFFERENTIAL DIAGNOSIS OF FURIOUS RABIES  
• Delerium tremens 
• Botulism 
• Diphtheria 
• Drug ingestion (phenothiazines and amphetamines) 
• Plant ingestion (Datura fastuosa) 
• Tetanus 
Paralytic rabies 
Accounting for under 20% of human cases, paralytic rabies tends to 
follow either bites from vampire bats16 or bites in people who have 
received pre-exposure vaccination. After the usual prodrome, a flaccid 
paralysis develops, usually in the bitten limb, which ascends (either 
symmetrically or asymmetrically) with pain and fasciculation in the 
affected muscles. There is often mild sensory disturbance. Paraplegia 
and sphincter disturbances follow, until eventually a fatal paralysis of 
the respiratory and deglutive muscles occur. Hydrophobia is rare but 
may be noted as a few spasms of the laryngeal muscles in the terminal 
phase. These patients may survive for up to 30 days without ITU 
support.  
DIFFERENTIAL DIAGNOSIS OF PARALYTIC RABIES  
• Guillain-Barré syndrome 
• Polio 
• Herpes simiae encephalitis 
• Arbovirus encephalitis 
Laboratory diagnosis 
There are two main avenues available in making the diagnosis. 
Firstly, the offending animal should be captured if possible. Brain 
biopsy provides samples of brain tissue, which can then be examined, 
and rabies antigen can be detected within a few hours by direct 
immunofluorescence or PCR. If the animal is not overtly "rabid", it can 
be observed for a period of 10 days. At any sign of infection or 
deterioration, the animal should be killed and the brain tested. Animals 
behaving strangely should be killed and examined as soon as possible 
after the bite or exposure.  
In a patient presenting with suspected rabies, demonstration of 
viral RNA by PCR or viral antigen in skin biopsies allows the earliest 
diagnosis (immunofluorescence highlights it in nerve twiglets). An 
alternative source for investigation is corneal scrapings; however, this 
site is not as sensitive as a neck skin biopsy. Rabies antibodies are not 
usually detectable in CSF or serum until the eighth day of illness in 
unvaccinated patients,18 and in most cases of rabies, patients have died 
before an antibody response is detectable. A peripheral neutrophil 
leucocytosis is common in the early stages of the disease, but is not 
particularly helpful in reaching the diagnosis.  
A recent series in France compared the sensitivies of the various 
tests in a premorbid situation.  They all showed a high specificity 
approaching 100%.19 As is evident from these values, none of the tests 
have a high sensitivity and thus a high degree of clinical suspicion is 
needed, rather than relying on a negative result.  
The laboratory diagnosis of rabies pre-mortem has always been 
difficult, but PCR has improved the sensitivity of the tests on skin snips 
and saliva. Another new technique involves the inoculation of saliva into 
mice, which can then be examined with PCR to confirm the diagnosis.  
Once rabies symptoms have developed, treatment itself is mainly 
supportive, as the outlook is dismal. Patients must be heavily sedated in 
order to control their pain and terror. The mainstay of treatment is 
intensive care support, including paralysis, sedation, and ventilation. 
Ketamine has been suggested as an appropriate agent for this purpose.15 
Antiserum, antiviral agents, interferon, corticosteroids, and other 
immunosuppressants have all proved useless. 
Pre-exposure vaccination 
Pre-exposure vaccination carries some degree of protection for 
the individual. It does not aim to provide full immunity, but does 
provide extra protection to allow the bitten individual time to seek 
administration of immunoglobulin and/or further vaccination. Pre-
exposure vaccination is currently offered to those at risk of infection, 
either occupationally or through travel.  
Currently, the course involves three doses of tissue culture 
vaccine given into the deltoid on days 0, 3, and 28. The seroconversion 
rate is 98.2%.23,24 Antibody levels need not be checked unless the patient 
is at particularly high risk of infection (for example, rabies laboratory 
staff). Otherwise, boosters can be given between 6 and 24 months to 
prolong protection.24 Currently the recommendation for vaccination 
includes those at risk occupationally and those intending to travel to 
rabies endemic areas for periods of more than 30 days.25  
By far the best means of prevention is to avoid coming into 
contact with rabid animals, and education for travellers to how to avoid a 
dangerous bite is central to prevention. Precautions include wearing long 
trousers, ignoring free roaming cats and dogs, and the immediate 
washing of wounds. 
Wound treatment 
The rabies virus is easily killed by sunlight, soap, and drying. 
Wound care is central to the prevention of rabies infection. In 
experimental animals, rabies transmission can be almost completely 
prevented by local wound treatment given within the first 3 hours after 
exposure, adequate wound cleaning can greatly reduce the risks of 
infection. 
Where possible, wound care should include infiltration with local 
anaesthetic. The wound should then be thoroughly scrubbed with water 
and either iodine solution, 40–70% alcohol, or quaternary ammonium 
compounds (cetrimide 0.1% BPC), all of which have a proven lethal 
effect on the rabies virus.  
During wound care, the edges of the wound must be scrubbed 
and any puncture wound must be cleaned thoroughly including the 
deepest parts. After scrubbing, the wound should be thoroughly rinsed 
with saline and covered with a simple dressing. Appropriate antibiotics 
should be used if indicated.  
Post-exposure prophylaxis involves a multifaceted approach 
combining wound care, passive treatment with immunoglobulin, and 
active vaccination.  
The aim of post-exposure prophylaxis is to neutralise inoculated 
virus before it can enter the nervous system of the patient. Although time 
is of the essence, there is a definite window of up to 2 hours before 
detrimental effects ensue.  
POST EXPOSURE PROPHYLAXIS 
The indication for post-exposure vaccination with or without 
rabies immune globulin depends on the type of contact with the rabid 
animal. Types of contact are:  
Category I  
Touching or feeding animals, licks on the skin; category II - 
nibbling of uncovered skin, minor scratches or abrasions without 
bleeding, licks on broken skin;  
Category II   
Single or multiple transdermal bites or scratches, contamination 
of mucous membrane with saliva from licks. For category I no treatment 
is required, whereas for category II immediate vaccination and for  
Category III  
Immediate vaccination and administration of rabies immune 
globulin are recommended in addition to immediate washing and 
flushing of all bite wounds and scratches. Depending on vaccine type, 
the post-exposure schedule prescribes intramuscular doses of 1 ml or 0.5 
ml given as four to five doses over four weeks. For rabies-exposed 
patients who have previously undergone complete pre-exposure 
vaccination or post-exposure treatment with cell-derived rabies 
vaccines, two intramuscular doses of a cell-derived vaccine separated by 
three days are sufficient. Rabies immune globulin treatment is not 
necessary in such cases. The same rules apply to persons vaccinated 
against rabies who have demonstrated neutralizing antibody titres of at 
least 0.5 IU/ml.  
Passive immunisation 
This is achieved using human rabies immunoglobulin (HRIG) 
which functions by neutralizing the rabies virus both locally and 
systemically within the first week prior to the body’s own response to 
the vaccine. HRIG also appears to enhance the patient’s T cell response 
to the vaccine. The initial dose of immunoglobulin is 20 IU/kg body 
weight,26 which should be infiltrated around the wound site as much as 
is anatomically feasible, the remainder being injected intramuscularly 
into an area as far as possible from the vaccination site. If HRIG is 
unavailable, WHO recommendations are to use equine immunoglobulin 
at a dose of 40 IU/kg. Technically immunoglobulin should be given in 
all previously unvaccinated cases but it is especially important in those 
identified as at severe risk of infection (particularly head and neck 
wounds or multiple deep bites). Hypersensitivity reactions will occur in 
between 1 and 6% of individuals, and resuscitation equipment must be 
available at all times.  
Unfortunately the HRIG is very expensive,27 and as such is not 
often available in the third world countries that carry the highest risk 
rabid animal injuries. Equine or ovine rabies immunoglobulin may be 
available, but they carry an allergic risk.  
Fully vaccinated patients should receive a booster vaccine on 
days 0 and 3, into the deltoid muscle28; this site has been shown to 
produce the best antibody titre available. Unvaccinated patients should 
receive doses on days 0, 3, 7, 14 and 28. The full course need not be 
given in the ED, but adequate arrangements must be made for follow up 
with the general practitioner.  
Patients given the current vaccine reported approximately 30–
74% levels of pain, swelling, erythema, and itching around the injection 
site.27 Systemic reactions such as headache, nausea, and abdominal pains 
were reported in 5–40% of recipients, most commonly in those patients 
receiving more frequent boosters. The overall anaphylaxis rates is 
0.1%.29  
In those patients currently taking immunosuppressive medications, these 
should be discontinued if at all possible to improve the immune response 
to the vaccine. Pregnancy is not a contraindication to giving either the 
vaccine or immunoglobulin, and the vaccine dosage is the same for 
children and adults. 
MANAGEMENT OF HUMAN RABIES  
Once rabies symptoms have developed, treatment itself is mainly 
supportive, as the outlook is dismal. Patients must be heavily sedated in 
order to control their pain and terror. The mainstay of treatment is 
intensive care support, including paralysis, sedation, and ventilation. 
Ketamine has been suggested as an appropriate agent for this purpose.15 
Antiserum, antiviral agents, interferon, corticosteroids, and other 
immunosuppressants have all proved useless.  
Three patients have been documented as surviving rabies 
infection.22 All had some degree of pre-exposure or post-exposure 
prophylaxis and lengthy stays in the intensive therapy unit to control 
other complications, including electrolyte disturbances, cardiac failure, 
raised intracranial pressure, convulsions, and hyperpyrexia. They have 
usually been left with neurological deficits.15  
 
MATERIALS AND METHODS 
 
STUDY DESIGN  :  
 Prospective and descriptive study  
STUDY PLACE :  
 Institute of Social Paediatrics, 
Govt. Stanley Medical College and Hospital, 
Chennai-600 001. 
STUDY PERIOD :  
 October 2004 – September 2005. 
SAMPLE SIZE :  
 1450 cases 
 
INCLUSION CRITERIA 
All the children bitten by the dog who attended the OP during the 
study period are included in our study. 
EXCLUSION CRITERIA  
All the other animal bites admitted for the purpose of antirabies 
vaccine are excluded from our study.  Children suffering from major 
health illness are excluded from our study. 
METHODOLOGY 
Using proforma every caretaker and children are interviewed 
separately in examination room to keep the secrecy of questions. 
Only after completing all the proformas caretakers are briefed 
about the queries they ask out  the DOs and DON’Ts about dog bite and 
rabies vaccination. 
DOG BITE WOUND CLASSIFICATION 
Dog Bite wound are classified according to severity of the wound 
according to WHO recommendation. 
SEVERITY TYPE OF CONTACT 
Category I Touching (or) Feeding of animals licks on Intact 
Skin 
Category II Nibbling of uncovered skin, minor scratches or 
abrasions without bleeding  
Licks on Broken skin 
Category III Single or multiple transdermal bites or scratches  
Lick on the mucous membrane. 
 
 RABIES VACCINATION 
Administration of purified inactivated rabies vaccine, prepared on 
verocells containing  
Freeze dried rabies vaccine (Wistar Strain Rabies PM / WI 38-
1503-3M) 
Produced on verocell line, inactivated and purified. 
Such that > 2.5 IU before and after heating for 1 month at 37oC 
Maltose – upto 1 immunising dose 
Human plasma albumin upto 1 immunising dose. 
Diluents 0.4% sodium chloride solution 0.5ml. 
Administered by Residential interns in Upper Arm in Deltoid or 
Middle Thigh is monitored for development of any immediate side 
effects. 
 
 
OBSERVATION AND RESULTS 
This study on epidemiology of Dog Bitten Children, knowledge, 
attitude and practice regarding rabies, first aid to dog bite and rabies 
vaccination and rabies vaccine side effects was conducted on dog bitten 
children admitted in dog bite ward in Jawaharlal Nehru Institute of 
Social Pediatric under Stanley Medical College during the period of 
6.10.04 to 6.9.05. 
Average number of dog bitten children administered antirabies 
vaccine during this study period is 25.1%.  Out of 3,80,000 children 
attended OP during this study period 1,450 children are dog bitten 1 out 
of 262 children attend OP for dog bite i.e. dog bite incidence is 0.4%. 
Using stratified random sampling technique children are 
interview in our prospective study. 
Proposing test is used for all statistical analysis. 
AGE DISTRUBTION OF DOG BITTEN CHILDREN 
Age Group Dog Bitten Children Percentage 
 
0-3 year 213 15% 
4-6 year 389 27% 
7-0 year 391 27% 
10-12 year 457 31% 
There is significantly decreased incidence of dog bite in the 0-3 
age group.(P<0.001) 
SEX DISTRIBUTION OF DOG BITTEN CHILDREN 
Sex No. of Cases Percentage 
Male 973 67% 
Female 477 32% 
Total 1450 100% 
There is increased incidence in male child. 
REGIONAL DISTRIBUTION OF DOG BITTEN CHILDREN 
1334 (92%) Children bitten by dog hail from urban and 116 (8%) 
coming from rural areas.  More urban children bitten by dog probably as 
we done the study in urban hospital. 
SOCIO ECONOMIC DISTRIBUTION OF DOG BITTEN 
CHILDREN 
754(52%) Children admitted in dog bite ward belong to class IV 
of modified Kuppusamy Socio Economic Scale.  464(32%) children 
belong to class V, 232(16%) children belong to class III No children 
admitted from class I & II. 
FAMILY TYPE DISTRIBUTION OF DOG BITTEN CHILDREN 
1160(80%) Children are reared in nuclear family. 
290(20%) Children are from joint family. 
Significantly lower number of joint family children are bitten by 
dog.   
(P<0.001, Z-32.3 difference 60%. Diff 60% (CI 57-63). 
PLACE DISTRIBUTION OF DOG BITE 
870 (60%) Children are bitten by the dog in street.   
580 (40%) Children are bitten in home 
Significant number of children are bitten in street than home 
(P<0.001) Z=10.7. Diff. 20% (CI 16-24). 
TIME DISTRIBUTION OF DOG BITE 
1044 (72%) Children are bitten by the dog in night. 
406(28%) Children are bitten in day time. 
Using proportion test significant number of children are bitten by 
the dog in night, than daytime (P0.001, Z 23.7 difference 44%, 95% CI 
(41-47). 
ACTIVITY DISTRIBUTION DURING DOG BITE 
754 (52%) Children are bitten by dog when the children walk or 
play in the street. 
464 (32%) Children bitten while they play with the dog. 
174(12%) Children are bitten during feeding the dog. 
58(4%) Children are bitten while they are eating. 
Significant no of children are bitten by dog when they walk /play 
in the street or playing with the dog. 
DOG BITE SITE DISTRIBUTION. 
696 (48%) Children dog bites in lower limb. 
580 (40%) Children dog bites in upper limb. 
116 (8%) Children dog bites in Head and Neck. 
58 (4%) Children dog bite in Chest and Abdomen. 
Significant number of children are bitten in upper limbs and 
lower limb than head & neck and trunk.  
DOG TYPE DISTRIBUTION 
Type of Dog No. of Children Percentage 
Stray 870 60% 
Pet 580 40% 
 
870(60%) Children are bitten by stray dogs. 
580(40%) Children are bitten by per dogs. 
Significant number of children are bitten by stray dog than pet dog 
(P<0.001, Z10.7, difference 20% CI-16-24). 
DOG VACCINATION STATUS 
Vaccination Status of 
the Dog 
No. of Children Percentage 
Vaccinated Dog  232 16% 
Non-Vaccinated Dog 1218 84% 
 
232(16%) Children are bitten by vaccinated dog. 
1218(84%) Children are bitten by unvaccinated / dogs whose vaccine 
status not known. 
Significant number of children are bitten by unvaccinated dog than 
vaccinated dog. (P,0.001, Z-36.6, Difference 68%, C.I. 65-71). 
DOG BITE CATEGORY DISTRIBUTION OF DOG BITTEN 
CHILDREN 
753(52%) of children had class III dog bite. 
697(48%) children sustain class II dog bite. 
VACCINE SIDE EFFECTS 
Local side Effects Systemic Side Effects 
like Fever and 
Myalgia 
Systemic Allergic 
Reaction 
14(0.96%) 29(2%) 1(0.0689%) 
 
14Children (0.96%) developed local side effects at the 
vaccination site like Pain, Erythema and Tenderness. 
29Children (2%) developed mild systemic side effects like fever. 
1 Child (0.0689%) developed systemic allergic reaction in the 
form of urticaria and fever. 
KNOWLEDGE, ATTITUDE AND PRACTICE STUDY ON 
RABIES 
 Yes No Statistical Analysis 
Rabies is fatal 1218 232 P0.001 Z30.6 Diff. 68%  
Even Dog Scratch is 
Dangerous 
638 812 P.001 Z=6.4 Diff. 12%  
Even Puppy Dog Bite is 
Dangerous 
1044 406 P0.001 Z=23.7 Diff.44% 
Even Vaccinated Pet 
Dog Bite is Dangerous 
464 (32%) 986 P.001 Z=19.3 Diff. 36%  
 
Native Medicine is 
enough for Dog Bite 
348 (24%) 1102 P.001 Z=27.9 Diff. 52%  
Fate of the Dog 406 (38%0 1044  P.001 Z=23.7 Diff. 44   
 
Care takers with adequate knowledge, good attitude and correct practice 
1218 caretakers know Rabies is fatal. 
638 caretakers know even dog scratch could be dangerous. 
1044 caretakers known that puppy bite could be dangerous. 
464 caretakers known that even vaccinated pet dog bite could be 
dangerous. 
1102 caretakers know that native medicine alone is not enough for dog 
bite. 
406 caretakers observe the dog. 
WRONG (OR) INADEQUATE KNOWLEDGE ATTITUDE AND 
PRACTICE. 
 Yes No P Z Difference 
(C I) 
First Aid 
Knowledge 
406 (28%) 1044(72%) <0.001 23.7 44% (44-41) 
First Aid 
Practice 
232(16%) 1218(84%) P<0.001 36.6 68% (65-71) 
Even 
Scratch 
Need 
Vaccination 
580(40%) 870(60%) P<0.001 10.7 20% (16-24) 
Pre 
Exposure 
Prophylaxis 
290(20%) 1160(80%) P<0.001 32.3 60% (57-63) 
Food 
Restriction 
and change 
in daily 
activity of 
living 
1102(76%) 348(24%) P<0.001 27.9 52% (49-50) 
 
232 caretakers did not know that rabies is fatal. 
812 caretakers did not know even rabid dog scratch can be dangerous. 
406 caretakers did not know even puppy bite can be dangerous. 
986 caretakers did not know even pet dog bite can be dangerous. 
348 caretakers presume that native medicine alone is enough for dog 
bite. 
1044 caretakers chased away the dog or killed the dog or don’t know the 
fate of the dog. 
Knowledge attitude and practice study on pre & Post exposure 
prophylaxis 
ADEQUATE KNOWLEDGE ATTITUDE AND PRACTICE ON 
PRE AND POST EXPOSURE PROPHYLAXIS 
Only 406 caretakers (28%) have correct first aid knowledge. 
Only 232 caretakers (16%) practiced first aid correctly. 
Only 580 caretakers (40%) know that even scratch need vaccination. 
Only 290 caretakers (20%) know about pre exposure prophylaxis. 
Only 348 caretakers (24%) did not impost any food restriction on 
change in daily activity of living. 
WRONG OR INADEQUATE KNOWLEDGE, ATTITUDE AND 
PRACTICE ON PRE AND POST EXPOSURE PROPHYLAXIS 
1044 caretakers (72%) did not have correct first aid knowledge. 
1218 caretakers (84%) practiced wrong first aid like applying madar 
juice, lime. 
870 caretakers (60%) do not know that even scratch need vaccination . 
1160 caretakers (80%) do not know about pre exposure prophylaxis. 
1102 caretakers (76%) impose food restriction and change in daily 
activity of living like not consuming EGG and non-veg.  Change in 
daily activity of living like not taking head bath during vaccination 
course. 
DISCUSSION 
General incidence of dog bite is 0.5%  (South East Journal of 
Tropical Medicine 1998; 19;563-9).   
In our study the incidence is 0.4% 
AGE GROUP DISTRIBUTION OF DOG BITTEN CHILDREN 
There is increased incidence in school children in 5-12 age group 
in a study conducted in infection diseases hospital in 1997 published in 
Indian Journal of Practical Pediatrics ; 2004; Sep-15, 71, (217-220). 
In the study conducted in institute of child health, Chennai by Dr. 
Parthasarathy et. Al. from 1982-1983, published in Indian pediatrics, 
1984 July-Vol 21-549-554.   
In ICH study age distribution is  
Age Dog Bite Incidence 
<1 2% 
1-3 26% 
4-6 28% 
7-10 35% 
11-12 9% 
 
In our study the age distribution is 
Age Group Incidence Percentage 
0-3 213 15 
4-6 389 27 
7-9 391 27 
10-12 457 31 
 
Increased incidence of Dog Bite as the age increases because the 
children’s increased  play and activity as the age progress more so in age 
group of 10,11,12 years as they walk alone without care takers to 
School, Tuition, Shop and their interest in out door games. 
Significantly low incidence of dog bite in infants and toddlers of 
0-3 years age groups because they stay mostly in home, always watched 
by caretakers as they are dependant for most their daily activity of 
living.  
SEX DISTRIBUTION OF DOG BITTEN CHILDREN 
In our study more number 67% of boys are bitten by dogs than 
girls (32.9%). 
In the study conducted in Infectious Disease Hospital, Delhi, in 
1999 published in Indian Journal of Practical Pediatrics 2004, 9;15; 
71,(217-30)  Male to Female Ratio is 4:1 But it is conducted in all 
patients but our study is specific to children < 12 years 
In the study conducted in pediatric age group in Institute of Child 
Health during January - 82 to June 83, Male to female ratio is 2:1. 
Significant no of boys sustain dog bite because they are more 
interested in outdoor play and activity. 
REGIONAL DISTRIBNUTION OF DOG BITTEN CHILDREN  
More number of urban children (92%) are dog bitten than rural 
children (8%)as we conducted in urban hospital. 
SOCIO ECONOMIC DISTRIBUTION OF DOG BITTEN 
CHILDREN 
52% class IV children, 32% class V children and 16% class III 
children are dog bitten.  There is no class I & II children because they 
are not admitted in dog bite ward as free ARV is given for whose 
monthly income is less than Rs.1000. More class IV and class V are 
admitted because of their poor socio-economic environment and their 
caretakers illiteracy. 
TYPE OF FAMILY DISTRIBUTION OF DOG BITTEN 
CHILDREN 
80% of Dog bitten children hail from nuclear family. 
20% of dog bitten children are from joint family. 
Significantly decreased number of joint family children are bitten 
by dog as there is more number of care takers are available to watch the 
children. 
PLACE DISTRIBUTION OF DOG BITTEN CHILDREN 
Dog bite occur more in street (60%) than home (40%).   There is 
less change of dog bite in home because there will be care taker in 
home.  Dog bite is more by stray dogs as per our study and many other 
studies so dog bite occurs more in street than home. 
TIME DISTRIBUTION OF DOG BITE 
72% of children are bitten by dog in night 6 pm – 6 am than by 
day (28%) between 6 am – 6 pm.  As there is more chance of children 
play in the evening or walking in the street for tuition or shopping. 
ACTIVITY AT BITE DISTRIBUTION 
52% children are bitten by dog when the children walk or play in 
the street. 
32% children are bitten when they play with the dog. 
12% children are bitten while feeding the dog. 
4% of children are bitten while the children are eating the food. 
Significantly more number of children are bitten by the dog while 
they walk or play in the street as they are easily accessible to street dogs 
and moving or running away from dog which provoke the dog to bite. 
DOG BITE ANATOMICAL DISTRIBUTION 
In our study more number of children are bitten in lower limb 
48% , upper limb 40%, compared to head & neck (8%) and chest & 
abdomen (4%).  
In a study in Infectious Disease Hospital, Delhi, published in 
Indian Journal of Practical Pediatrics 2004, 9.15, 71, (217-220) 55.2%, 
30.7%, 2.1%, 12% bitten in lower limb, upper limb, chest & back and 
head & neck. 
 Face is the target in 70% of children one study in U.S. (America 
Academy of Pediatrics 15;4:2001) where pet dog bite is more common 
than stray dog.  So children got head & neck bite when they play with 
the pet dogs. 
In various Indian studies and also in out study lower limb 
sustained significant dog bite because in India stray dog population is 
more than pet dog and also lower limb is in easy reach for stray dog 
when they chase the children. 
TYPE OF DOG DISTRIBUTION 
In our study significant number of children are bitten by stray 
dogs (60%) than per dogs (40%) are as there is more number of stray 
dogs to pet dogs.   
In the study conducted Infectious Diseases Hospital, Calcutta 
from January 1974 Dec. 1980 Published in Journal of Indian Medial 
Association – Vol – 81; 69-74, stray dogs bite is 94.5% pet dog bite is 
5.5%. 
DOG VACCINATION STATUS DISTRIBUTION 
More number of children are bitten by unvaccinated or 
vaccination status not known dogs (16%) than vaccinated dogs (84%) as 
it is not a rule or mandatory to vaccinate the pet dog in India. 
In India, government or any voluntary organization does not do 
vaccination of stray dog. 
DOG BITE CATEGORY DISTRIBUTION  
In out study 52% children sustained category III and 48% 
sustained category II dog bite wound. 
In the study conducted in rabies research center at Central Rabies 
Institute, Casauli from 1986-1989 by Dr. S.N.Madhusudhanan et.al. 
published in Journal of Indian Medical Association 1992, Vol-90, 169-
171, 27.5% of the study group sustained class II bite, 72.5% sustained 
class II bite 
VACCINE SIDE EFFECTS 
In out study using purified Vero cell culture vaccine, few a mild 
systemic side effects 2% and mild local side effects 1% and 1 case of 
systemic allergic reaction occurred no major side effects or death 
occurred due to vaccine side effects. 
In the study published in Journal of allergy using human diploid 
cell culture vaccine in 1987;80;861-8. 
Mild local side effects are – 30 – 70%. 
Moderate side effects are – 5 – 40%. 
Study on purified vero cell vaccine indicate mild to moderate side 
effects 2-7% local or general side effects 5-10%. 
KNOWLEDGE ATTITUDE AND PRACTICE STUDY ABOUT 
RABIES. 
16% caretakers did not know that rabies is fatal. 
56% did not know that scratch by dog is dangerous. 
28% unaware that even puppy bite is harmful.  
68% do not know that even vaccinated pet dog bite is dangerous. 
76% wrongly believe that native medicine alone is enough for 
dog bite.   
Only 28% know that the dog has to be observed not to be killed 
or chased away. 
As evidenced by out study low knowledge and poor attitude and 
wrong practices about dog bite is prevalent due to illiteracy and 
ignorance as caretakers of our study group is 32% illiterate, 52% are 
primary school level. 
KNOWLEDGE ATTITUDE AND PRACTICE STUDY ON PRE 
AND POST EXPOSURE 
72% care takers don’t have first aid knowledge. 
84% practice wrong first aids like madar juice, lime application. 
In the study conducted Infectious Diseases Hospital, Calcutta between 
1986-1989 published in Journal of Medical Associations, Vol-90, No 7, 
July 1992 by madusudhana et.al only 7% received correct first aid. 
In our study 60% don’t know that even scratch need vaccination.   
80% don’t know about pre exposure prophlaxis.   
76% impose unnecessary food restriction of avoiding EGG, non 
Vegetarian food, change in daily activity of living like not applying oil, 
not taking head bath after dog bite.    
Low level of knowledge, poor attitude and wrong practices can be 
corrected by information, education and councelling by health workers, 
anganwadis, teachers, NGO’s and Government employees. 
SUMMARY 
Dog bite occur more in children of age group 4-12 years (67%), 
from class IV (52%), class V (32%) socio economic group, 80% from 
nuclear families, more in the streets (60%) than home (40%), more in 
the night (72%) than day time (28%) more during walk or play in street 
(52%) more in lower limb (48%) and upper limb (40%) more by stray 
dogs (60%) than pet dog (40%) of which (84%) of the dogs are un 
vaccinated.  And the children sustained dog bite category III (52%) 
category II (48%). 
Purified vero-cell culture rabies vaccine side effects are Mild 
Local side effects are 1%, mild General side effects are 2%. 
16% care takers don’s know that rabies is fatal 56% don’t know 
even dog scratch is dangerous 28% don’t know even puppy bite can be 
harmful, 68% don’t know even vaccinated pet dog bite is dangerous 
76% presume that native medicine alone is enough only 28% care takers 
observed the dog. 
72% care takers did not have first aid knowledge 84% have 
strong first aid practices 60% did not know that even scratch need 
vaccination 80% do not know about pre exposure prophylaxis 76% 
impose unnecessary food restriction and change in daily activity of 
living. 
CONCLUSIONS 
Rabies remains the 10th commonest cause of death due to 
infection and dog bite is the second most common injury.  Dog bite pre 
valance is 200 – 800 / 1,00,000.  In India 3 people die of rabies per 
1,00,000. Of which pediatric age group comprises 44%. 
Even after the development of the safe third generation rabies 
vaccine with few mild side effect and no major side effect and easy 
availability of these rabies vaccines at free of cost in all the government 
hospitals and government Medical Colleges still rabies death occur.   
In our study increased incidence (67%) is in the age group (4-12) 
due to their play or walking alone in the streets (60%) by un vaccinated 
(84%) stray dogs (60%) more in the night time (72%) more in the 
extremities (88%) more from the nuclear families (80%).  
It can be prevented by keeping the children in home in night 
away from stray dogs, train them not to run away from dog or go to 
them with out stretched hand, more than one care takers watching the 
children. 
Urgent need to control stray dog population by castration.  
Vaccinating 80% of stray gods will stop the virus multiplication in 
environment. 
Poor knowledge wrong attitude towards rabies as such and 
neglect of dog bite due to puppies, vaccinated pet dogs, scratches by 
dogs, practice of native medicines and application of madar juice, lime 
to dog bite wound can be changed with information through media, 
education through school and counseling by health care providers. 
The importance of observation of dog for 10 days after bite, 
knowledge about first aid and correct practice of first aid of simple soap 
wash for 10 minutes itself prevent 80% rabies. 
Knowledge about pre exposure prophylaxis of pet handlers which 
can be made mandatory and vaccination even for scratch or vaccinated 
pet dog bite and puppies bite, prevention of food restriction and changes 
in daily activity of living can be done by advertisement information by 
media, education through conventional and non- conventional teaching 
and counseling by health care providers, teachers, anganwadi workers 
and non government organization, government employees which are all 
available and accessible to every rural or urban population or India. 
 
KEY TO THE MASTER CHART 
 
Sex  :  
1 Male 
2 Female 
 
Regional distribution of dog bitten children  :  
1 Rural 
2 Urban 
 
Socio-economic Class   
III, IV, V, (Modified Kuppusamy Socioeconomic Scale) 
 
Family  Type :  
1 Nuclear 
2 Joint 
 
Place of Dog Bite  
1 Home 
2 Street 
 
Time of Dog Bite  
1 Day 
2 Night 
 
Activity at bite  
1 Play in the street 
2 Feeding the dog 
3 Eating 
4 Play with the dog 
 
Site of Dog bite  
1 Upper limb 
2 Head and neck 
3 Trunk 
4 Lower limb 
 
Type of Dog   
1 Stray 
2 Pet 
 
Vaccination status of the dog  
1 Vaccinated 
2 Un-vaccinated 
 
Category of Bite  
2  Class II  
3 Class III 
 
Side effects of  Rabies Vaccine :  
1 Mild local 
2 Mild Systemic 
3 Systemic allergic 
 
Rabies is fatal   
1 Yes  
2 No 
 
Scratches Fatal :  
1 Yes 
2 No 
 
Puppy bite is fatal  
1 Yes 
2 No 
 
Vaccinated pet dog bite is fatal :  
1 Yes 
2 No 
 
Even scratch need vaccination :  
1 Yes 
2 No 
 
Pre-exposure prophylaxis :  
1 Yes 
2 No 
Native medicine is  enough for dog bite :  
1 Yes 
2 No 
 
Fate of the Dog :  
1) Observed 
2)  Killed / Chased away / now known 
 
First Aid knowledge : 1) Present 2) Absent 
 
First aid practice : 1) Correct 2) Not correct 
Food Restriction and change in daily activity of living is necessary 
 1) Yes  2) No 
PROFORMA 
EPIDEMIOLOGICAL PROFILE OF DOG BITE VICTIM 
 
Name :  
Age :  
Sex : M / F 
Residential  Address : 
Place  : Rural / Urban 
 Father Mother 
Education    
Occupation   
Socio-Economic Status    
: 
Income   
 
Socio-Economic Scale      : I  / II / III / IV / V 
Type of Family : Nuclear / Joint 
Dog Bite at  : Home/Street 
Time of Dog Bite at : Day (6am-6pm) / Night (6am-6pm)     
What the child did : Play in the street  / Feeding / Eating / Play with 
the dog 
at the time of bite 
Where did the dog bite : Upper Limb / Head & Neck / Trunk / 
  Lower limb   
Type of Dog : Pet / Stray  
Vaccination status of  : Vaccinated / Unvaccinated  
the Dog   
Type of Dog Bite  : I / II / III
 KNOWLEDGE, ATTITUDE &  
PRACTICE STUDY ABOUT 
RABIES AND  
PRE AND POST EXPOSURE PROPHYLAXIS  
 
1) Rabies is fatal      : Yes / No 
2) Even Scratch is dangerous     : Yes / No 
3) Even puppy bite is dangerous   : Yes / No 
4) Even vaccinated healthy pet dog bite   : Yes / No 
is dangerous 
5) Even Scratch Needs  vaccination  :  Yes / No 
 
6) Do you know about vaccine for pet rearers  : Yes /No 
7) Native treatment is enough for rabies  : Yes / No 
8) What did you done after dog bitten you  : Observed / Killed  or chased away  
9) What is the first aid measure to be given : Correct / Not correct 
after dog bite 
10) First aid given after dog bite is  : Correct / Incorrect 
11) Is food restriction and change in daily  : Yes / No 
Activity of living is necessary. 
 
 
  
 
